Global Hospital Infection Prevention and Control Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

“Global Hospital Infection Prevention and Control Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global hospital infection prevention and control market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global hospital infection prevention and control market report has been segmented on the basis of product, antimicrobial drugs, infections, and region.

Introduction:

Controlling the spread of diseases and minimizing the number of healthcare-associated infections are among the primary concerns for any healthcare facility across the globe. Infection control is a series of steps that healthcare facilities and hospitals take in order to prevent the spread of infectious diseases. According to the Centers for Disease Control and Prevention in 2017, one out of every twenty hospitalized patients is affected with some form of healthcare-associated infection

Market Dynamics:

Key factors expected to drive growth of the global hospital infection prevention and control market is rising prevelance of infections across the globe. In addition, increasing healthcare expenditure, growing incidence of chronic diseases, increase in healthcare utilization, and growing geriatric population are some other factors expected to drive growth of the global hospital infection prevention and control market. Furthermore, increasing hospital admissions and outpatient visits, rising number of surgical procedures, initiatives by NGO and Government to spread the awareness regarding infection prevention and management, are some other factors expected to drive growth of the target market over the forecasted period. However, strict regulation is the factors expected to hamper growth of the global hospital infection prevention and control market over the forecast period.

Trends and Opportunity:

Prominent players are focusing on partnering with various end users such as hospitals and medical laboratory in order to expand its geographical footprint is key trends witnessed in the target market, currently.

Regional Analysis:

The market in North America is expected to dominate in the global hospital infection prevention and control market. This is primarily attributed to rising number of surgical procedure in countries in the region. According to the Centers for Disease Control and Prevention (CDC) approximately 300,000 cases of surgical site infections (SSIs) occurrences each year, and second most prevelance is hospital acquired infection (HAI) in the US. The market in Asia Pacific is expected to be an emerging market for the global hospital infection prevention and control market, and is expected to register highest CAGR over the forecast period, rising healthcare expenditure and growing geriatric population in countries in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register significant higher revenue growth in the global hospital infection prevention and control market over the forecast period.

GLOBAL HOSPITAL INFECTION PREVENTION AND CONTROL MARKET SEGMENTATION:

Segmentation by product:

• Infection Prevention Supplies
• Infection Prevention Equipment
• Infection Prevention Services

Segmentation by antimicrobial drugs:

• Anti-bacterial Drug
• Anti-Viral Drug
• Anti-fungal Drug
• Vaccine

Segmentation by infections:

• Microbial infections
  • Bacterial infection
  • Viral Infection
  • Fungal Infection
• Hospital Acquired Infection
  • Central line associated bloodstream infection (CLABSI)
  • Catheter associated Urinary Tract infection
  • Surgical site infection
  • Ventilator associated Pneumonia (VAP) infection
• Community acquired infection
  • Methicillin resistant Staphylococcus aureus (MRSA) infection
  • Community acquired pneumonia

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa